Meta-analysis of early phase II studies with paroxetine in hospitalized depressed patients.
Byrne
M M
MM
Beecham Pharmaceuticals Research Division, Medicinal Research Centre, Harlow, Essex, United Kingdom.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000639:Amitriptyline / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000188:drug therapy*; D004311:Double-Blind Method; D004341:Drug Evaluation; D005260:Female; D006778:Hospitals, Psychiatric; D006801:Humans; D008297:Male; D015201:Meta-Analysis as Topic; D008875:Middle Aged; D017374:Paroxetine; D010880:Piperidines / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012702:Serotonin Antagonists / Q000627:therapeutic use*
D000928:Antidepressive Agents; D010880:Piperidines; D012702:Serotonin Antagonists; D000639:Amitriptyline; D017374:Paroxetine